| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、经营活动产生的现金流量: | | | | |
| 销售商品、提供劳务收到的现金 | 404,482,246.23 | 240,191,341.56 | 119,953,376.19 | 512,784,677.22 |
| 收到的税费返还 | 88.03 | 88.03 | - | - |
| 收到其他与经营活动有关的现金 | 15,894,186.46 | 13,904,552.91 | 3,482,683.67 | 7,998,551.61 |
| 经营活动现金流入小计 | 420,376,520.72 | 254,095,982.5 | 123,436,059.86 | 520,783,228.83 |
| 购买商品、接受劳务支付的现金 | 294,256,405.93 | 180,396,649.57 | 50,997,133.36 | 351,446,684.23 |
| 支付给职工以及为职工支付的现金 | 32,610,461.18 | 22,670,461.05 | 13,658,859.57 | 40,355,847.83 |
| 支付的各项税费 | 15,805,813.89 | 7,838,140.7 | 2,849,017.04 | 16,370,103.33 |
| 支付其他与经营活动有关的现金 | 27,001,198.58 | 19,497,562.13 | 12,770,167.68 | 42,002,054.65 |
| 经营活动现金流出小计 | 369,673,879.58 | 230,402,813.45 | 80,275,177.65 | 450,174,690.04 |
| 经营活动产生的现金流量净额 | 50,702,641.14 | 23,693,169.05 | 43,160,882.21 | 70,608,538.79 |
| 二、投资活动产生的现金流量: | | | | |
| 取得投资收益收到的现金 | 1,551,123.48 | 1,551,123.48 | - | 1,400,482.83 |
| 处置固定资产、无形资产和其他长期资产收回的现金净额 | 10,977,236 | - | - | 40,585.84 |
| 收到的其他与投资活动有关的现金 | 967,067,389.32 | 710,082,838.43 | 161,179,571.87 | 1,124,224,456.06 |
| 投资活动现金流入小计 | 979,595,748.8 | 711,633,961.91 | 161,179,571.87 | 1,125,665,524.73 |
| 购建固定资产、无形资产和其他长期资产支付的现金 | 4,705,470.62 | 3,994,960 | 93,917 | 10,727,897.1 |
| 投资支付的现金 | 76,120,000 | 76,120,000 | - | 30,000,000 |
| 支付其他与投资活动有关的现金 | 1,068,153,650 | 793,053,750 | 256,000,000 | 1,215,213,051.99 |
| 投资活动现金流出小计 | 1,148,979,120.62 | 873,168,710 | 256,093,917 | 1,255,940,949.09 |
| 投资活动产生的现金流量净额 | -169,383,371.82 | -161,534,748.09 | -94,914,345.13 | -130,275,424.36 |
| 三、筹资活动产生的现金流量: | | | | |
| 取得借款收到的现金 | 125,856,045.46 | 54,232,086.54 | 19,507,732.74 | 119,738,939.88 |
| 收到其他与筹资活动有关的现金 | 15,887,994.31 | 13,450,000 | 13,450,000 | 31,860,941.67 |
| 筹资活动现金流入小计 | 141,744,039.77 | 67,682,086.54 | 32,957,732.74 | 151,599,881.55 |
| 偿还债务支付的现金 | 81,250,387.09 | 29,717,445.49 | 22,719,342.99 | 232,184,279.84 |
| 分配股利、利润或偿付利息支付的现金 | 18,798,436.44 | 18,436,317 | 102,236.73 | 21,829,403.12 |
| 其中:子公司支付给少数股东的股利、利润 | 16,240,000 | 16,240,000 | - | 4,640,000 |
| 支付其他与筹资活动有关的现金 | 3,774,822.58 | 3,509,145.49 | 10,606,907.59 | 25,447,133.89 |
| 筹资活动现金流出小计 | 103,823,646.11 | 51,662,907.98 | 33,428,487.31 | 279,460,816.85 |
| 筹资活动产生的现金流量净额 | 37,920,393.66 | 16,019,178.56 | -470,754.57 | -127,860,935.3 |
| 四、汇率变动对现金及现金等价物的影响 | -25,404.84 | -25,404.83 | 7,519.59 | 179,135.29 |
| 五、现金及现金等价物净增加额 | -80,785,741.86 | -121,847,805.31 | -52,216,697.9 | -187,348,685.58 |
| 加:期初现金及现金等价物余额 | 523,076,837.72 | 523,076,837.72 | 523,076,837.72 | 710,425,523.3 |
| 期末现金及现金等价物余额 | 442,291,095.86 | 401,229,032.41 | 470,860,139.82 | 523,076,837.72 |
| 补充资料: | | | | |
| 净利润 | - | 18,225,584.46 | - | 21,804,616.51 |
| 资产减值准备 | - | -1,539,833.4 | - | 6,731,676.78 |
| 固定资产和投资性房地产折旧 | - | 10,045,530.74 | - | 28,409,812.76 |
| 其中:固定资产折旧、油气资产折耗、生产性生物资产折旧 | - | 10,045,530.74 | - | 28,409,812.76 |
| 无形资产摊销 | - | 128,482.44 | - | 256,964.88 |
| 固定资产报废损失 | - | - | - | 3,624,915.39 |
| 公允价值变动损失 | - | -49,555.8 | - | -76,162.81 |
| 财务费用 | - | 478,449.99 | - | -7,875,073.89 |
| 投资损失 | - | -7,059,266.84 | - | -6,354,759.01 |
| 递延所得税 | - | -94,307.79 | - | -634,911.91 |
| 其中:递延所得税资产减少 | - | -121,776.78 | - | -630,547.4 |
| 递延所得税负债增加 | - | 27,468.99 | - | -4,364.51 |
| 存货的减少 | - | -8,169,770.19 | - | 53,365,782.43 |
| 经营性应收项目的减少 | - | -29,415,069.47 | - | 9,512,855.76 |
| 经营性应付项目的增加 | - | 40,301,897.71 | - | -39,585,740.18 |
| 现金的期末余额 | - | 401,229,032.41 | - | 523,076,837.72 |
| 减:现金的期初余额 | - | 523,076,837.72 | - | 710,425,523.3 |
| 现金及现金等价物的净增加额 | - | -121,847,805.31 | - | -187,348,685.58 |
| 公告日期 | 2025-10-30 | 2025-08-26 | 2025-04-29 | 2025-03-25 |
| 审计意见(境内) | | | | 标准无保留意见 |